6. パーキンソン病 Parkinson disease Clinical trials / Disease details


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05225324
(ClinicalTrials.gov)
June 3, 202126/1/2022A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)Equfina Tablet 50 mg Post Marketing Surveillance ProtocolParkinson DiseaseDrug: Equfina 50 mgEisai Korea Inc.NULLRecruiting18 YearsN/AAll600Korea, Republic of
2NCT04724109
(ClinicalTrials.gov)
October 14, 202021/1/2021A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)Protocol for Study EQF01S: General Drug Use-Results Observational Study of Equfina® TABLETS 50 mg Observational Study on the Incidences of Adverse Drug Reactions in Patients With Parkinson's Disease (Including Patients With Hepatic Impairment)Parkinson DiseaseDrug: EqufinaEisai Co., Ltd.NULLCompletedN/AN/AAll1088Japan